ARCHIVES

NCI Advisors Criticize a Biomarker Study Touted as High Priority for NCI and FDA.

This article is from The Cancer Letter archive.

Vol. 33 No. 27 | July 13, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: Berger Named Dean At Case Western; Hayes Heads Lombardi’s Breast Programs

September 6, 1996

Funding Opportunities

April 26, 2002

DeLap: Seven Years In industry Provided View Of Pressures On Drug Developers

August 2, 1996

Letter: Cancer Centers Need Ingenuity To Continue Clinical Research

October 27, 1995

NCI Moves Ahead To Find “Less-Hazardous” Cigarette

April 19, 1974

Announcement, RFA On Drug Discovery Groups Coming

December 10, 1982